Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 COA Metrics: Testing Comparison

HPLC (High-Performance Liquid Chromatography) Purity. Percentage of target peptide vs impurities and synthesis byproducts ≥98% with chromatogram showing single dominant peak Confirms synthesis cleanliness and absence of truncated sequences or reagent contamina

This comparison does not assign a generated winner or score.

  • HPLC (High-Performance Liquid Chromatography)
  • Purity. Percentage of target peptide vs impurities and synthesis byproducts
  • ≥98% with chromatogram showing single dominant peak
  • Confirms synthesis cleanliness and absence of truncated sequences or reagent contamination
  • Without HPLC data and chromatogram, purity claims are unverifiable
  • Mass Spectrometry (ESI-MS or MALDI-TOF)
  • Molecular weight. Verifies correct peptide sequence and detects substitution errors
  • 1419.53 g/mol ±1 Da (BPC-157 free peptide) or ~1479 g/mol (acetate salt)
  • Distinguishes BPC-157 from similar-length peptides and confirms amino acid sequence accuracy
  • Measured mass must match expected value. 'calculated' entries without data are insufficient
  • Peptide Content (% w/w)
  • Net peptide mass as percentage of total powder weight (accounts for counterions like acetate)
  • 70–85% typical for acetate salts
  • Critical for accurate dosing. Purity measures compound cleanliness, content measures actual peptide quantity
  • A 98% pure peptide with 75% content means 25% of the vial weight is non-peptide mass (acetate salt)
  • Sterility Testing (USP <71>)
  • Bacterial and fungal contamination via 14-day incubation in growth media
  • No growth detected in thioglycollate or soybean-casein digest media
  • Prevents introducing live contaminants into cell cultures or animal models
  • Absence of sterility data disqualifies the peptide for any in vivo or sterile in vitro use
  • Endotoxin Testing (LAL Assay)
  • Lipopolysaccharide contamination from gram-negative bacteria (measured in EU/mg)
  • <1.0 EU/mg for research-grade peptides; <0.5 EU/mg preferred for in vivo studies
  • Endotoxins trigger immune responses that confound experimental results even at sub-infectious levels
  • High endotoxin levels invalidate immunological and inflammatory response studies
  • Heavy Metals Panel
  • Trace contamination from synthesis reagents or equipment (lead, arsenic, cadmium, mercury)
  • <10 ppm total heavy metals; individual limits per ICH Q3D guidelines
  • Heavy metal contamination introduces cytotoxicity and long-term accumulation risks
  • Absence of heavy metals testing is a red flag for peptides intended for extended dosing protocols
More references

Related material